You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 16, 2025

Drug Price Trends for SLEEP AID


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for SLEEP AID

Average Pharmacy Cost for SLEEP AID

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug NameNDCPrice/Unit ($)UnitDate
SLEEP AID 25 MG TABLET 24385-0441-64 0.10776 EACH 2025-03-19
SLEEP AID 25 MG TABLET 70000-0567-01 0.10776 EACH 2025-03-19
SLEEP AID 50 MG/30 ML LIQUID 70000-0174-01 0.00972 ML 2025-03-19
SLEEP AID 25 MG SOFTGEL 70000-0584-01 0.20894 EACH 2025-03-19
SLEEP AID 50 MG SOFTGEL 70000-0527-01 0.10423 EACH 2025-03-19
SLEEP AID 50 MG/30 ML LIQUID 70000-0174-02 0.01363 ML 2025-03-19
>Drug Name>NDC>Price/Unit ($)>Unit>Date
Showing 1 to 6 of 6 entries

Best Wholesale Price for SLEEP AID

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)UnitDatesPrice Type
SLEEP AID (DOXYLAMINE) United Drug Supply, Inc. 00113-0441-64 32 5.57 0.17406 EACH 2023-12-01 - 2028-11-30 FSS
SLEEP AID (DOXYLAMINE) United Drug Supply, Inc. 00113-0441-73 16 3.72 0.23250 EACH 2023-12-01 - 2028-11-30 FSS
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Unit>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 1 to 2 of 2 entries

Sleep Aids Market Analysis and Price Projections

Introduction to Sleep Aids Market

The sleep aids market is a rapidly growing sector driven by the increasing prevalence of sleep disorders, technological advancements, and rising awareness about the importance of quality sleep. Here’s a comprehensive analysis of the market, including its size, growth projections, key drivers, and challenges.

Market Size and Growth Projections

The global sleep aids market is substantial and continues to expand. As of 2024, the market size is estimated to be around USD 85.84 billion and is projected to reach USD 119.66 billion by 2029, growing at a CAGR of 6.90% during the forecast period[1][3][4].

By 2032, the market is expected to grow even further, reaching USD 158.28 billion, with a CAGR of 7.04% from 2023 to 2032[4].

Regional Market Analysis

North America

North America holds the largest market share in the sleep aids sector. This dominance is attributed to the high prevalence of insomnia and other sleep disorders, driven by underlying conditions such as depression and anxiety. The region also benefits from technological advancements and frequent product launches[1][4].

Asia-Pacific

The Asia-Pacific region is the fastest-growing market for sleep aids. Factors such as increasing disposable income, a rising geriatric population, and growing awareness about sleep health contribute to this growth[1].

Key Drivers of the Market

Increasing Prevalence of Sleep Disorders

The growing prevalence of insomnia and other sleep disorders is a significant driver. Studies have shown that factors like unemployment, low socioeconomic status, chronic illnesses, and stressful life events are linked to higher rates of insomnia, particularly among certain demographics[1].

Technological Advancements

Continuous technological progress in sleep apnea devices and other sleep aids is enhancing the market. Innovations in diagnostic and treatment options are making sleep aids more effective and accessible[3][4].

Rising Awareness and Disposable Income

Increasing awareness about the benefits of using sleep aids and rising disposable income, especially in developing economies, are driving the market forward. Government funding and endorsements for healthier sleep approaches also contribute to market growth[3][4].

Challenges and Limitations

Side Effects and Long-Term Efficacy

One of the significant challenges is the potential side effects of sleep aids medication. Additionally, some sleep aids have limited long-term efficacy, leading to the development of tolerance and the need for higher doses or alternative treatments[3][4].

Cost and Accessibility

The high cost of prescription sleep aids and limited insurance coverage create a financial barrier for many individuals. This can discourage people from seeking treatment, despite the growing need for sleep aids[4].

Impact of COVID-19

The COVID-19 pandemic has had a mixed impact on the sleep aids market. On one hand, the pandemic exacerbated sleep disorders due to increased stress and lifestyle changes. On the other hand, it highlighted the importance of sleep health, leading to increased awareness and adoption of sleep aids[3].

Prescription vs. Over-the-Counter (OTC) Sleep Aids

Prescription Sleep Aids

Prescription sleep aids, such as Belsomra and zolpidem, have been significant in the market. However, the erosion of branded drug sales due to the growing adoption of generics is a challenge. Generic products offer equal efficacy at a lower cost, affecting the sales of branded prescription sleep aids[2].

OTC Sleep Aids

OTC sleep aids are expected to grow more quickly than prescription sleep aids. The convenience and lower cost of OTC options make them more appealing to consumers, contributing to their rapid growth[2].

Price Projections

General Trends

The cost of sleep aids, particularly prescription drugs, is expected to rise. Employers predict an average increase of 8% in prescription drug costs in 2025, with outpatient prescription drugs seeing an 11.4% increase[5].

Specific to Sleep Aids

While the overall trend indicates rising costs, the sleep aids market is also influenced by the shift towards generics and OTC products, which can mitigate some of the cost increases. However, the high cost of some prescription sleep aids and the limited long-term efficacy of certain products will continue to be factors in the market[2][4].

Market Concentration and Major Players

The sleep aids market has a medium level of concentration, with several major players competing in the space. These companies are investing in research and development to launch new products and expand their market presence[1].

Conclusion

The sleep aids market is poised for significant growth driven by increasing prevalence of sleep disorders, technological advancements, and rising awareness. However, challenges such as side effects, long-term efficacy, and cost barriers need to be addressed.

Key Takeaways

  • The global sleep aids market is projected to reach USD 119.66 billion by 2029 and USD 158.28 billion by 2032.
  • North America holds the largest market share, while the Asia-Pacific region is the fastest-growing.
  • Technological advancements and increasing awareness about sleep health are key drivers.
  • Side effects, long-term efficacy, and cost barriers are significant challenges.
  • Prescription sleep aids face competition from generics, while OTC sleep aids are growing rapidly.

FAQs

What is the projected market size of the sleep aids market by 2029?

The sleep aids market is expected to reach USD 119.66 billion by 2029[1].

Which region is the largest market for sleep aids?

North America is the largest market for sleep aids, driven by the high prevalence of insomnia and other sleep disorders[1][4].

What are the key drivers of the sleep aids market?

Key drivers include the increasing prevalence of sleep disorders, technological advancements, and rising awareness about sleep health[1][3][4].

What challenges does the sleep aids market face?

Challenges include side effects of sleep aids medication, limited long-term efficacy, and high costs that create financial barriers[3][4].

How is the COVID-19 pandemic impacting the sleep aids market?

The pandemic has exacerbated sleep disorders but also highlighted the importance of sleep health, leading to increased awareness and adoption of sleep aids[3].

Are prescription sleep aids or OTC sleep aids growing faster?

OTC sleep aids are expected to grow more quickly than prescription sleep aids due to their convenience and lower cost[2].

Sources

  1. Mordor Intelligence: Sleep Aids Market - Report & Industry Trends.
  2. Sleep Review Magazine: OTC Sleep Aids Expected to Grow More Quickly Than Prescription Sleep Aids.
  3. Allied Market Research: Sleep Aids Market Size, Share | Key Analysis | Forecast 2030.
  4. The Brainy Insights: Sleep Aids Market Size, Trends and Forecast to 2032.
  5. Managed Healthcare Executive: Employers Predict Drug Prices Will Increase in 2025, Survey Shows.

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.